Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Legal Brawl Over Patent Rules Creates Wide Trenches As More Groups Weigh In

Executive Summary

The legal battle over the U.S. Patent and Trademark Office's efforts to limit certain patent filings intensified last month as various parties jumped into the fray

You may also be interested in...

PTO Hit With Second Lawsuit Opposing Continuation Rules As GSK Joins Fray

GlaxoSmithKline has filed suit against the Patent and Trademark Office to block new rules limiting the number of continuation applications a patent holder can file

New Patent Rules May Hurt Biotech Industry; Limits Set On Certain Filings

The U.S. Patent and Trademark Office is implementing new rules on patent filings that will make it tougher for biotechnology companies to protect their inventions

Ruth Bader Ginsburg’s Impact On Pharma, From Patents To The First Amendment

Justice Ginsburg wrote two decisions in pharmaceutical related-cases over the past decade, joined the majority in opinions on the scope of patents, and dissented in decisions giving protection to generic manufacturers and speech of pharmaceutical companies. Her death could impact the outcome of cases challenging the Affordable Care Act.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts